Frankfurt - Delayed Quote EUR
Bristol-Myers Squibb Company (BRM.F)
42.17
-0.63
(-1.47%)
As of 4:02:43 PM GMT+2. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BOERNER CHRISTOPHER S Chief Executive Officer | Conversion of Exercise of derivative security | Mar 10, 2025 | 125,439 |
| ELKINS DAVID VINCENT Chief Financial Officer | Conversion of Exercise of derivative security | Mar 10, 2025 | 223,605 |
| GALLMAN CARI Officer | Conversion of Exercise of derivative security | Mar 10, 2025 | 8,322 |
| HOCH LYNELLE BAUMGARDNER Officer | Conversion of Exercise of derivative security | Mar 10, 2025 | 4,711 |
| LENKOWSKY ADAM Officer | Conversion of Exercise of derivative security | Mar 10, 2025 | 19,240 |
| LEUNG SANDRA General Counsel | Conversion of Exercise of derivative security | Mar 10, 2025 | 465,374 |
| MEYERS GREGORY SCOTT Chief Technology Officer | Conversion of Exercise of derivative security | Mar 10, 2025 | 16,102 |
| PLENGE ROBERT M Officer | Conversion of Exercise of derivative security | Mar 10, 2025 | 18,134 |
| POOLE AHN AMANDA Officer | Conversion of Exercise of derivative security | Mar 10, 2025 | 5,368 |
| SHANAHAN KARIN Officer | Conversion of Exercise of derivative security | Apr 1, 2025 | 15,075 |
Related Tickers
4AB.DU AbbVie Inc
157.60
+1.81%
IDP.HM Biogen Inc
103.35
-0.86%
PFE.DU Pfizer Inc
19.92
+1.06%
LILY34.SA Eli Lilly and Company
161.21
+3.00%
NOV.DE Novo Nordisk A/S
54.91
+1.24%
ABBV AbbVie Inc.
179.69
+1.49%
MRK Merck & Co., Inc.
77.86
-1.12%
JNJ Johnson & Johnson
154.56
-0.53%
PFE Pfizer Inc.
22.69
+1.34%
NVO Novo Nordisk A/S
62.38
+1.76%